Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity

Scientists identified the inhibitory molecular mechanisms of metformin on programmed death ligand 1 expression in cancer cells and programmed death 1 expression in immune cells.